Startups and Tranfers

BACK

MEDICAL TECHNOLOGIES

Folia Bioteh

Folia Bioteh

Versatile platform of recombinant pseudo-viral particles

Folia Biotech is a Canadian clinical stage biotechnology company that has developed and patented PAL technology, a versatile platform with adjuvant, vaccine and immunomodulatory properties. Based on PAL technology, Folia Biotech is dedicated to improving the effectiveness of vaccines and designing innovative vaccines to combat infectious, non-infectious and immune diseases, with the ultimate goal of improving human health globally.

Entrepreneur

Denis Leclerc, Ph.D.
Founder
CHU de Québec, Université Laval